CN115176994A - Composite plant beverage suitable for metabolic syndrome patients and preparation method thereof - Google Patents
Composite plant beverage suitable for metabolic syndrome patients and preparation method thereof Download PDFInfo
- Publication number
- CN115176994A CN115176994A CN202110363288.9A CN202110363288A CN115176994A CN 115176994 A CN115176994 A CN 115176994A CN 202110363288 A CN202110363288 A CN 202110363288A CN 115176994 A CN115176994 A CN 115176994A
- Authority
- CN
- China
- Prior art keywords
- plant beverage
- composite plant
- parts
- metabolic syndrome
- patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 74
- 239000002131 composite material Substances 0.000 title claims abstract description 74
- 208000001145 Metabolic Syndrome Diseases 0.000 title claims abstract description 36
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 241000196324 Embryophyta Species 0.000 claims abstract description 73
- 240000005662 Aronia melanocarpa Species 0.000 claims abstract description 33
- 235000007425 Aronia melanocarpa Nutrition 0.000 claims abstract description 33
- 239000000284 extract Substances 0.000 claims abstract description 26
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 22
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 22
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 30
- 230000001954 sterilising effect Effects 0.000 claims description 27
- 239000004386 Erythritol Substances 0.000 claims description 14
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 14
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 14
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 14
- 235000019414 erythritol Nutrition 0.000 claims description 14
- 229940009714 erythritol Drugs 0.000 claims description 14
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 14
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 14
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 14
- 239000004376 Sucralose Substances 0.000 claims description 12
- 235000019408 sucralose Nutrition 0.000 claims description 12
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 12
- 229920001353 Dextrin Polymers 0.000 claims description 10
- 239000004375 Dextrin Substances 0.000 claims description 10
- 235000019425 dextrin Nutrition 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 8
- 235000003599 food sweetener Nutrition 0.000 claims description 8
- 239000003765 sweetening agent Substances 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000013325 dietary fiber Nutrition 0.000 claims description 6
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 4
- 235000015165 citric acid Nutrition 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000011975 tartaric acid Substances 0.000 claims description 4
- 235000002906 tartaric acid Nutrition 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 13
- 230000009286 beneficial effect Effects 0.000 abstract description 11
- 230000035622 drinking Effects 0.000 abstract description 10
- 230000007774 longterm Effects 0.000 abstract description 10
- 230000003647 oxidation Effects 0.000 abstract description 9
- 238000007254 oxidation reaction Methods 0.000 abstract description 9
- 239000000419 plant extract Substances 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 description 20
- 241000699670 Mus sp. Species 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000004537 pulping Methods 0.000 description 5
- 238000012371 Aseptic Filling Methods 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 235000021022 fresh fruits Nutrition 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229940126673 western medicines Drugs 0.000 description 4
- 238000007789 sealing Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241001444063 Aronia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000693079 Maloideae Species 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229940055416 blueberry extract Drugs 0.000 description 1
- 235000019216 blueberry extract Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000020237 cranberry extract Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to the technical field of composite nutriments, in particular to a composite plant beverage suitable for patients with metabolic syndrome and a preparation method thereof. The composite plant beverage comprises the following components in parts by weight: 8 to 20 portions of aronia melanocarpa concentrated solution and 0.5 to 1.5 portions of tartary buckwheat extract. The invention solves the problem that the prior art has no composite beverage aiming at the metabolic syndrome. The main functional components of the composite plant beverage are aronia melanocarpa concentrated solution and tartary buckwheat extract, and the prepared composite plant beverage has the effects of reducing blood sugar, resisting oxidation and the like when being drunk on one hand, and the plant extract is not easy to cause dependence on the other hand, so that the composite plant beverage is beneficial to long-term drinking.
Description
Technical Field
The invention relates to the technical field of composite nutriments, in particular to a composite plant beverage suitable for patients with metabolic syndrome and a preparation method thereof.
Background
The metabolic syndrome refers to a pathological state of metabolic disorder of substances such as protein, fat, carbohydrate and the like in a human body, is a complex metabolic disorder syndrome, and is a risk factor for causing diabetic cardiovascular and cerebrovascular diseases. More and more studies have shown that anti-oxidation is an important step in metabolic syndrome, as free radicals or oxidants break down cells and tissues, affect metabolic function, and cause different health problems. If the excess oxidative free radicals can be eliminated, many diseases caused by free radicals and related to aging can be prevented. Such as common cancers, arteriosclerosis, diabetes, cataracts, cardiovascular diseases, senile dementia, arthritis, etc., which are considered to be associated with free radicals.
In the prior art, various medicines, in particular various western medicines, are generally used for treating symptoms of the metabolic syndrome. However, various western medicines have certain side effects and are not beneficial to long-term administration.
Disclosure of Invention
In view of the above-mentioned shortcomings of the prior art, the present invention aims to provide a composite plant beverage suitable for metabolic syndrome patients, which is used for solving the problem that the prior art does not have composite beverage for metabolic syndrome, and at the same time, the present invention also provides a preparation method of the composite plant beverage suitable for metabolic syndrome patients. The aronia melanocarpa concentrated solution and the tartary buckwheat extract are prepared into the composite plant beverage, so that the effects of reducing blood sugar, resisting oxidation and the like are achieved when the composite plant beverage is drunk, and the dependence is not easily caused by the plant extract, so that the composite plant beverage is beneficial to long-term drinking.
In order to attain the above and other related objects,
the invention provides a composite plant beverage suitable for patients with metabolic syndrome, which comprises the following components in parts by weight: 8 to 20 portions of aronia melanocarpa concentrated solution and 0.5 to 1.5 portions of tartary buckwheat extract.
Aronia melanocarpa, commonly known as Aronia melanocarpa, belongs to the genus Aronia of the subfamily Maloideae of the family Rosaceae, and is used as a natural antihypertensive and antiatherosclerotic drug. The antioxidant effect of aronia melanocarpa extract can be evaluated by different in vitro tests. The superoxide radical scavenging ability test shows that the extract of aronia melanocarpa has stronger ability than other extracts, and is 5 times of blueberry extract, 8 times of cranberry extract and more than 4 times of cowberry extract.
The Fagopyrum tataricum contains high nutritive value protein, high fiber, vitamins B1, B2 and B6, and flavonoid (quercetin and rutin), and Fagopyrum tataricum extract has effects of resisting oxidation, lowering blood pressure, lowering blood sugar and reducing blood lipid. The radix Et rhizoma Fagopyri Tatarici extract can be purchased from Shanghai Cyanine industry Co., ltd, hubei Yuancheng Saishuan science and technology Co., ltd, shenzhen Sendy Soy Biotechnology Co., ltd, etc.
The aronia melanocarpa concentrated solution and the tartary buckwheat extract are prepared into the composite plant beverage, so that the effects of reducing blood sugar, resisting oxidation and the like are achieved when the composite plant beverage is drunk, and the dependence is not easily caused by the plant extract, so that the composite plant beverage is beneficial to long-term drinking.
In an embodiment of the present invention, the composite plant beverage comprises the following components in parts by weight: 8 to 20 parts of aronia melanocarpa concentrated solution, 0.5 to 1.5 parts of tartary buckwheat extract, 4 to 10 parts of low molecular water-soluble dietary fiber, 4 to 11 parts of sweetening agent and 0.001 to 0.005 part of sour agent.
The low-molecular water-soluble dietary fiber, the sweetening agent and the sour agent are added on the basis of the aronia melanocarpa concentrated solution and the tartary buckwheat extract, so that the absorption can be promoted, the mouthfeel of the composite plant beverage can be improved, the composite plant beverage has a refreshing taste, and the composite plant beverage is beneficial to long-term drinking of people.
The composite plant beverage has a refreshing taste, and has the effects of resisting oxidation, lowering blood pressure, reducing blood sugar and reducing blood fat after long-term drinking.
In one embodiment of the present invention, the low molecular water-soluble dietary fiber is resistant dextrin;
the sour agent is at least one of citric acid, tartaric acid, malic acid and tartaric acid;
the sweetener is at least one of erythritol, sucralose, galactooligosaccharide, stachyose and aspartame.
In an embodiment of the present invention, the composite plant beverage comprises the following components in parts by weight: 8 to 20 parts of aronia melanocarpa concentrated solution, 0.5 to 1.5 parts of tartary buckwheat extract, 4 to 10 parts of resistant dextrin, 4 to 10 parts of erythritol, 0.05 to 0.15 part of stachyose, 0.05 to 0.15 part of galacto-oligosaccharide, 0.005 to 0.015 part of sucralose and 0.001 to 0.005 part of citric acid.
The sweetener of the composite plant beverage is erythritol, sucralose, galactooligosaccharide and stachyose. Erythritol is 100% natural and derived from corn, is sugar-like in consistency and taste, but has a calorific value (calorie value) close to zero, and is more suitable for patients with metabolic syndrome. Stachyose and galactooligosaccharide are excellent nutrient sources and effective proliferation factors of beneficial bacteria such as bifidobacterium, lactobacillus acidophilus and the like in human intestinal tracts, and have the effects of regulating intestinal flora, improving lipid metabolism and reducing serum cholesterol.
In an embodiment of the present invention, the composite plant beverage comprises the following components in parts by weight: 12 to 16 parts of aronia melanocarpa concentrated solution, 0.75 to 1.0 part of tartary buckwheat extract, 5 to 8 parts of resistant dextrin, 5 to 8 parts of erythritol, 0.075 to 0.10 part of stachyose, 0.075 to 0.10 part of galactooligosaccharide, 0.0015 to 0.002 part of sucralose and 0.0015 to 0.002 part of citric acid.
In one embodiment of the present invention, the composite plant beverage further comprises 60 to 80 parts of water.
In a second aspect of the present invention, there is provided a method for preparing the above composite plant beverage suitable for patients with metabolic syndrome, comprising: the raw materials are uniformly mixed according to the weight part ratio, and then are packaged after high-temperature sterilization to obtain the traditional Chinese medicine.
The preparation method of the compound plant beverage is simple, the cost is low, and compared with western medicines, the compound plant beverage has no side effect and high safety. The composite plant beverage has the advantages of fewer raw materials, simple preparation process and lower cost, is suitable for patients with metabolic syndrome, and has the effects of resisting oxidation, lowering blood pressure, lowering blood sugar and lowering blood fat after long-term drinking.
In an embodiment of the present invention, the preparation process of the aronia melanocarpa concentrated solution is as follows: fresh or frozen Aronia melanocarpa fruit is used as raw material, and is subjected to pulping, juice filtering, sterilization and concentration to prepare concentrated juice.
In an embodiment of the present invention, the specific process of the high temperature sterilization comprises: sterilizing at 100-110 deg.c for 10-60 sec, cooling to 70-80 deg.c and sterilizing for 10-20 min.
In an embodiment of the present invention, the specific process of the high temperature sterilization includes: sterilizing at 105 deg.C for 30s, cooling to 75 deg.C, and sterilizing for 15min.
As mentioned above, the composite plant beverage suitable for the metabolic syndrome patients and the preparation method thereof have the following beneficial effects:
1. the aronia melanocarpa concentrated solution and the tartary buckwheat extract are prepared into the composite plant beverage, so that the effects of reducing blood sugar, resisting oxidation and the like are achieved when the composite plant beverage is drunk, and the dependence is not easily caused by the plant extract, so that the composite plant beverage is beneficial to long-term drinking.
2. The low-molecular water-soluble dietary fiber, the sweetening agent and the sour agent are added on the basis of the aronia melanocarpa concentrated solution and the tartary buckwheat extract, so that the absorption can be promoted, the mouthfeel of the composite plant beverage can be improved, the composite plant beverage has a refreshing taste, and the composite plant beverage is beneficial to long-term drinking of people.
3. The sweetener of the composite plant beverage is erythritol, sucralose, galactooligosaccharide and stachyose. Erythritol is 100% natural and derived from corn, resembles sugar in consistency and taste, but has a caloric value (calorie value) near zero, and is more suitable for patients with metabolic syndrome. Stachyose and galactooligosaccharide are excellent nutrient sources and effective proliferation factors of beneficial bacteria such as bifidobacterium, lactobacillus acidophilus and the like in human intestinal tracts, and have the effects of regulating intestinal flora, improving lipid metabolism and reducing serum cholesterol.
4. The preparation method of the compound plant beverage is simple, the cost is low, and compared with western medicines, the compound plant beverage has no side effect and high safety. The composite plant beverage has the advantages of fewer raw materials, simple preparation process and lower cost, is suitable for patients with metabolic syndrome, and has the effects of resisting oxidation, lowering blood pressure, lowering blood sugar and lowering blood fat after being drunk for a long time.
Detailed Description
The embodiments of the present invention are described below with reference to specific embodiments, and other advantages and effects of the present invention will be readily apparent to those skilled in the art from the disclosure of the present invention.
Example 1
A composite plant beverage suitable for metabolic syndrome patients comprises the following components in parts by weight: 9 parts of aronia melanocarpa concentrated solution, 0.5 part of tartary buckwheat extract (purchased from Shenzhen Shendi Biotech Co., ltd.), 4 parts of resistant dextrin, 4 parts of erythritol, 0.05 part of stachyose, 0.05 part of galactooligosaccharide, 0.005 part of sucralose, 0.001 part of citric acid and 60 parts of water.
The preparation method of the composite plant beverage suitable for the metabolic syndrome patients comprises the following steps:
s1, taking fresh fruits of aronia melanocarpa as raw materials, pulping, filtering, sterilizing and concentrating (the concentration ratio is 2;
s2, uniformly mixing the raw materials according to the weight part ratio;
and S3, feeding the mixture into a high-temperature sterilizer, sterilizing the mixture for 30S at 105 ℃, cooling the mixture to 75 ℃, sterilizing the mixture for 15min, and filling the mixture into a clean glass bottle under the aseptic filling condition to seal the bottle, thus obtaining the composite plant beverage.
Example 2
A composite plant beverage suitable for metabolic syndrome patients comprises the following components in parts by weight: 19 parts of aronia melanocarpa concentrated solution, 1.5 parts of tartary buckwheat extract (purchased from Shenzhen Sendi biotechnology limited), 10 parts of resistant dextrin, 10 parts of erythritol, 0.15 part of stachyose, 0.15 part of galactooligosaccharide, 0.015 part of sucralose, 0.005 part of citric acid and 80 parts of water.
The preparation method of the composite plant beverage suitable for the metabolic syndrome patients comprises the following steps:
s1, taking fresh fruits of aronia melanocarpa as raw materials, pulping, filtering, sterilizing and concentrating (the concentration ratio is 2;
s2, uniformly mixing the raw materials according to the weight part ratio;
and S3, sending the mixture into a high-temperature sterilizer, sterilizing the mixture for 30S at the temperature of 110 ℃, cooling the mixture to 70 ℃, sterilizing the mixture for 20min, and filling the mixture into a clean glass bottle under the aseptic filling condition for sealing to obtain the composite plant beverage.
Example 3
A composite plant beverage suitable for metabolic syndrome patients comprises the following components in parts by weight: 12 parts of aronia melanocarpa concentrated solution, 1.0 part of tartary buckwheat extract, 6 parts of resistant dextrin, 56 parts of erythritol, 0.10 part of stachyose, 0.10 part of galacto-oligosaccharide, 0.010 part of sucralose, 0.002 part of citric acid and 75 parts of water.
The preparation method of the composite plant beverage suitable for the metabolic syndrome patients comprises the following steps:
s1, taking fresh fruits of aronia melanocarpa as raw materials, pulping, filtering, sterilizing and concentrating (the concentration ratio is 2;
s2, uniformly mixing the raw materials according to the weight part ratio;
and S3, sending the mixture into a high-temperature sterilizer, sterilizing the mixture for 30S at 105 ℃, cooling the mixture to 75 ℃, sterilizing the mixture for 15min, and filling the mixture into a clean glass bottle under the aseptic filling condition for sealing to obtain the composite plant beverage.
Example 4
A composite plant beverage suitable for metabolic syndrome patients comprises the following components in parts by weight: 16 parts of aronia melanocarpa concentrated solution, 0.75 part of tartary buckwheat extract, 5 parts of resistant dextrin, 5 parts of erythritol, 0.075 part of stachyose, 0.075 part of galactooligosaccharide, 0.0075 parts of sucralose, 0.0075 parts of citric acid and 74 parts of water.
The preparation method of the composite plant beverage suitable for the metabolic syndrome patients comprises the following steps:
s1, taking fresh fruits of aronia melanocarpa as raw materials, pulping, filtering, sterilizing and concentrating (the concentration ratio is 2;
s2, uniformly mixing the raw materials according to the weight part ratio;
and S3, sending the mixture into a high-temperature sterilizer, sterilizing the mixture for 30S at 105 ℃, cooling the mixture to 75 ℃, sterilizing the mixture for 15min, and filling the mixture into a clean glass bottle under the aseptic filling condition for sealing to obtain the composite plant beverage.
The composite plant drinks prepared in examples 1 to 4 were used for the following tests:
selecting 6 mice for experiment, wherein four mice respectively drink the composite plant drink prepared in the examples 1-4, and the other two mice drink pure water; the addition amount is 20ml respectively in the morning, the noon and the evening.
Table 1
As can be seen from the data in table 1, the blood glucose concentration of the mice drinking the composite plant beverage prepared in examples 1 to 4 for a long period of time was effectively controlled, and the blood glucose of the mice gradually decreased. The composite plant beverage prepared in the embodiments 1 to 4 has the function of reducing blood sugar.
In conclusion, the aronia melanocarpa concentrated solution and the tartary buckwheat extract are prepared into the composite plant beverage, so that the aronia melanocarpa concentrated solution has the effects of reducing blood sugar, resisting oxidation and the like after being drunk, and the plant extract is not easy to cause dependence and is beneficial to long-term drinking. Therefore, the invention effectively overcomes various defects in the prior art and has high industrial utilization value.
The foregoing embodiments are merely illustrative of the principles and utilities of the present invention and are not intended to limit the invention. Those skilled in the art can modify or change the above-described embodiments without departing from the spirit and scope of the present invention. Accordingly, it is intended that all equivalent modifications or changes which can be made by those skilled in the art without departing from the spirit and technical spirit of the present invention be covered by the claims of the present invention.
Claims (10)
1. The composite plant beverage suitable for metabolic syndrome patients is characterized by comprising the following components in parts by weight: 8 to 20 portions of aronia melanocarpa concentrated solution and 0.5 to 1.5 portions of tartary buckwheat extract.
2. The composite plant beverage suitable for patients with metabolic syndrome according to claim 1, wherein: the composite plant beverage comprises the following components in parts by weight: 8 to 20 portions of aronia melanocarpa concentrated solution, 0.5 to 1.5 portions of tartary buckwheat extract, 4 to 10 portions of low molecular water-soluble dietary fiber, 4 to 11 portions of sweetening agent and 0.001 to 0.005 portion of sour agent.
3. The composite plant beverage suitable for patients with metabolic syndrome according to claim 2, wherein: the low-molecular water-soluble dietary fiber is resistant dextrin;
the sour agent is at least one of citric acid, tartaric acid, malic acid and tartaric acid;
the sweetener is at least one of erythritol, sucralose, galactooligosaccharide, stachyose and aspartame.
4. The composite plant beverage suitable for patients with metabolic syndrome according to claim 3, wherein: the composite plant beverage comprises the following components in parts by weight: 8 to 20 parts of aronia melanocarpa concentrated solution, 0.5 to 1.5 parts of tartary buckwheat extract, 4 to 10 parts of resistant dextrin, 4 to 10 parts of erythritol, 0.05 to 0.15 part of stachyose, 0.05 to 0.15 part of galacto-oligosaccharide, 0.005 to 0.015 part of sucralose and 0.001 to 0.005 part of citric acid.
5. The composite plant beverage suitable for patients with metabolic syndrome according to claim 4, wherein: the composite plant beverage comprises the following components in parts by weight: 12 to 16 parts of aronia melanocarpa concentrated solution, 0.75 to 1.0 part of tartary buckwheat extract, 5 to 8 parts of resistant dextrin, 5 to 8 parts of erythritol, 0.075 to 0.10 part of stachyose, 0.075 to 0.10 part of galactooligosaccharide, 0.0075 to 0.010 part of sucralose and 0.0015 to 0.002 part of citric acid.
6. The composite plant beverage suitable for patients with metabolic syndrome according to claims 1-5, wherein the composite plant beverage comprises the following components: the composite plant beverage also comprises 60-80 parts of water.
7. A method for preparing the composite plant beverage suitable for patients with metabolic syndrome according to any one of claims 1 to 6, comprising: the raw materials are uniformly mixed according to the weight part ratio, and then are packaged after high-temperature sterilization to obtain the traditional Chinese medicine.
8. The method for preparing the composite plant beverage suitable for patients with metabolic syndrome according to claim 7, wherein the aronia melanocarpa concentrated solution is prepared by the following steps: fresh or frozen Aronia melanocarpa is used as raw material, and is pulped, filtered, sterilized and concentrated to obtain concentrated juice.
9. The method for preparing the composite plant beverage suitable for patients with metabolic syndrome according to claim 7 or 8, wherein the composite plant beverage comprises: the high-temperature sterilization comprises the following specific processes: sterilizing at 100-110 deg.c for 10-60 sec, cooling to 70-80 deg.c and sterilizing for 10-20 min.
10. The method for preparing the composite plant beverage suitable for patients with metabolic syndrome according to claim 9, wherein the method comprises the following steps: the high-temperature sterilization comprises the following specific processes: sterilizing at 105 deg.C for 30s, cooling to 75 deg.C, and sterilizing for 15min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110363288.9A CN115176994A (en) | 2021-04-02 | 2021-04-02 | Composite plant beverage suitable for metabolic syndrome patients and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110363288.9A CN115176994A (en) | 2021-04-02 | 2021-04-02 | Composite plant beverage suitable for metabolic syndrome patients and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115176994A true CN115176994A (en) | 2022-10-14 |
Family
ID=83511218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110363288.9A Pending CN115176994A (en) | 2021-04-02 | 2021-04-02 | Composite plant beverage suitable for metabolic syndrome patients and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115176994A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100491106B1 (en) * | 2004-04-14 | 2005-05-27 | 주식회사 로제트 | health functional food with black fruits and vegetables, Manufacturing method thereof |
| CN112189771A (en) * | 2019-07-08 | 2021-01-08 | 不老莓生命技术(上海)有限公司 | Skin-beautifying composite plant enzyme beverage and preparation method thereof |
| CN112493480A (en) * | 2020-12-29 | 2021-03-16 | 广东绿宝堂健康科技有限公司 | Antioxidant composition and application thereof |
-
2021
- 2021-04-02 CN CN202110363288.9A patent/CN115176994A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100491106B1 (en) * | 2004-04-14 | 2005-05-27 | 주식회사 로제트 | health functional food with black fruits and vegetables, Manufacturing method thereof |
| CN112189771A (en) * | 2019-07-08 | 2021-01-08 | 不老莓生命技术(上海)有限公司 | Skin-beautifying composite plant enzyme beverage and preparation method thereof |
| CN112493480A (en) * | 2020-12-29 | 2021-03-16 | 广东绿宝堂健康科技有限公司 | Antioxidant composition and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111194841A (en) | Functional spirulina protein peptide drink capable of improving immunity and improving sleep quality | |
| CN103463457B (en) | Composite chewable tablet of Herba Dendrobii Hericium erinaceus (Bull. Ex Fr.) Pers. and preparation method thereof | |
| WO2022016774A1 (en) | Composition beneficial for regulating intestinal tract, promoting digestion and improving constipation, and preparation method therefor | |
| CN110839792A (en) | Composite fruit and vegetable juice beverage and preparation method thereof | |
| JP2016172761A (en) | Composition for controlling intestinal disorder and/or improving bowel movement | |
| CN112189771A (en) | Skin-beautifying composite plant enzyme beverage and preparation method thereof | |
| CN111329045A (en) | Three-high reducing tartary buckwheat coarse cereal powder | |
| CN111387381A (en) | Lonicera edulis compound fruit juice beverage and preparation method thereof | |
| CN109602013A (en) | Function of blood sugar reduction food | |
| KR100716123B1 (en) | Food composition comprising fermented dioscorea batatas decne. and the rhizoma thereof with lactic acid for preventing and improving constipation and obesity | |
| CN112704237A (en) | Vegetable peptide fat-reducing composition and eating method thereof | |
| CN104509901A (en) | Nymphaea tetragona plant probiotic multi-flavor health beverage | |
| Sebastián et al. | Prebiotics in beverages: from health impact to preservation | |
| CN104872775B (en) | A kind of compound fat-reducing solid beverage of green tea tea polysaccharide and application | |
| Aligita et al. | Antidiabetic activity of okra (Abelmoschus esculentus L.) fruit extract. | |
| CN109170863A (en) | A kind of functional sugar ferment and preparation method thereof | |
| CN111165709A (en) | Solid beverage with blood sugar control function and preparation method thereof | |
| CN115176994A (en) | Composite plant beverage suitable for metabolic syndrome patients and preparation method thereof | |
| CN112690385B (en) | Low-glycemic pitaya juice and preparation method thereof | |
| CN110279052A (en) | A kind of pectase beverage and preparation method thereof improving immunity | |
| Lancrajan | Aronia melanocarpa, a potential therapeutic agent | |
| KR20030080296A (en) | Composition containing saponin fraction and derivatives isolated from ginseng radix for preventing and treating allergy-mediated disease | |
| CN113875864A (en) | Blood sugar reducing and inhibiting tea and preparation method thereof | |
| Garcia-Lopez et al. | Guava purees with addition of agave fructans and natural sweeteners as potential functional products. | |
| CN113558103A (en) | Fermented milk containing plant polysaccharide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |